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Abstract
Background: Perfectionism can become a debilitating condition that may negatively affect functioning in multiple areas,
including mental health. Prior research has indicated that internet-based cognitive behavioral therapy can be beneficial, but few
studies have included follow-up data.
Objective: The objective of this study was to explore the outcomes at follow-up of internet-based cognitive behavioral therapy
with guided self-help, delivered as 2 separate randomized controlled trials conducted in Sweden and the United Kingdom.
Methods: In total, 120 participants randomly assigned to internet-based cognitive behavioral therapy were included in both
intention-to-treat and completer analyses: 78 in the Swedish trial and 62 in the UK trial. The primary outcome measure was the
Frost Multidimensional Perfectionism Scale, Concern over Mistakes subscale (FMPS CM). Secondary outcome measures varied
between the trials and consisted of the Clinical Perfectionism Questionnaire (CPQ; both trials), the 9-item Patient Health
Questionnaire (PHQ-9; Swedish trial), the 7-item Generalized Anxiety Disorder scale (GAD-7; Swedish trial), and the 21-item
Depression Anxiety Stress Scale (DASS-21; UK trial). Follow-up occurred after 6 months for the UK trial and after 12 months
for the Swedish trial.
Results: Analysis of covariance revealed a significant difference between pretreatment and follow-up in both studies.
Intention-to-treat within-group Cohen d effect sizes were 1.21 (Swedish trial; 95% CI 0.86-1.54) and 1.24 (UK trial; 95% CI
0.85-1.62) for the FMPS CM. Furthermore, 29 (59%; Swedish trial) and 15 (43%; UK trial) of the participants met the criteria
for recovery on the FMPS CM. Improvements were also significant for the CPQ, with effect sizes of 1.32 (Swedish trial; 95%
CI 0.97-1.66) and 1.49 (UK trial; 95% CI 1.09-1.88); the PHQ-9, effect size 0.60 (95% CI 0.28-0.92); the GAD-7, effect size
0.67 (95% CI 0.34-0.99); and the DASS-21, effect size 0.50 (95% CI 0.13-0.85).
Conclusions: The results are promising for the use of internet-based cognitive behavioral therapy as a way of targeting
perfectionism, but the findings need to be replicated and include a comparison condition.
(J Med Internet Res 2018;20(4):e154)   doi:10.2196/jmir.9823
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Introduction
Perfectionism has many positive features, such as striving for
excellence, but it can also have a negative impact in many areas,
including mental health [1]. Characterized by perfectionistic
strivings and perfectionistic concerns, perfectionism, instead of
helping the individual fulfill their goals, is associated with
avoidance, worry, procrastination, and self-criticism [2].
Perfectionism has also been found to be related to anxiety
disorders, depression, and eating disorders, in part by increasing
the odds of their occurrence, but also by interfering with
treatment progress, particularly by making behavior change
more difficult. In particular, certain populations tend to have
elevated perfectionism, such as people with eating disorders,
depression, social anxiety disorder, panic disorder, and
obsessive-compulsive disorder, compared with healthy controls
[3]. It has therefore been suggested that the use of psychological
treatments to address perfectionism could improve outcomes
for other conditions as well through transdiagnostic processes.
Moreover, the two higher-order dimensions of perfectionism
have also been found to be related to psychiatric disorders in
different ways. Perfectionistic strivings seem to be particularly
related to eating disorders, while perfectionism concerns are
primarily associated with depression and anxiety disorders [2].
This could imply that psychological treatments targeting
perfectionism might have to be adapted depending on the
psychiatric disorder [3]. Furthermore, elevated levels of
perfectionism can also be found among athletes and specific
sociodemographics [2], suggesting that there may be populations
that are particularly vulnerable to developing problems due to
perfectionism, and for whom psychological intervention could
prevent the development of further psychopathology.
A systematic review and meta-analysis by Lloyd et al [4]
provided evidence for the efficacy of cognitive behavioral
therapy (CBT) for managing perfectionism and for targeting
symptoms of depression and anxiety. Data gathered from 6
clinical trials that used the Frost Multidimensional Perfectionism
Scale, Concern over Mistakes subscale (FMPS CM) [5], a
widely distributed self-report measure of perfectionism, showed
that the average within-group Hedges g effect size between pre-
and posttreatment was 1.32 (95% CI 1.02-1.64). Using the
Clinical Perfectionism Questionnaire (CPQ), a self-report
measure to assess clinical perfectionism [6], 3 clinical trials
obtained comparable outcomes, with Hedges g effect sizes
ranging from 0.90 to 1.24. However, even though the findings
are promising, the meta-analysis did not provide any estimates
for follow-up data, making it unclear whether the outcomes
were maintained. A clinical trial by Egan et al [7], which
recruited participants through self-referral and included an
assessment at 6 months following treatment, indicated that CBT,
administered face-to-face or via the internet without any
guidance, had within-group Cohen d effect sizes of 2.11
(face-to-face; 95% CI 1.26-2.88) and 0.43 (unguided self-help;
95% CI –0.28 to 1.12) on the FMPS CM. For the CPQ, Cohen
d effect sizes were 1.61 (face-to-face; 95% CI 0.83-2.32) and
0.73 (unguided self-help; 95% CI –0.01 to 1.42). In terms of
recovery, based on a statistical cutoff and exceeding the Reliable
Change Index (RCI), 67% (face-to-face) and 40% (unguided
self-help) met the criteria for recovery at follow-up. This implies
that the benefits can be maintained and possibly even improved
from posttreatment. However, given the small sample size and
high attrition rate, these findings need to be interpreted
cautiously.
To extend the understanding of the treatment of perfectionism
and to evaluate the efficacy of internet-based CBT (ICBT), 2
clinical trials of treatment with guided self-help were conducted
in Sweden and the United Kingdom. The participants were
self-referred and assigned to self-help with guidance from a
therapist or to a waitlist control group. The results from pre- to
posttreatment were encouraging, obtaining within-group Cohen
d effect sizes of 1.03 (Swedish trial; 95% CI 0.69-1.36) and
1.47 (UK trial; 95% CI 1.06-1.86) for the FMPS CM. For the
CPQ, Cohen d effect sizes were 1.44 (Swedish trial; 95%
1.08-1.78) and 1.67 (UK trial; 95% CI 1.25-2.07) [8,9].
This study aimed to assess the long-term benefits of treating
perfectionism by determining the outcomes at follow-up for
those who received ICBT with guided self-help in the Swedish
and UK studies. However, given the differences between the 2
clinical trials on several key characteristics, for example their
inclusion and exclusion criteria, we present the results separately
rather than combined.
Methods
Participants and Procedure
Participants in both clinical trials consisted of self-referrals
recruited through advertisements in the media, social media,
and on campus grounds. Those interested in participating entered
a website to complete a screening process and provide electronic
informed consent. The websites were connected to a secure
Web-based interface where self-report measures were presented,
asynchronous communication with the study supervisors was
carried out, and treatment content was delivered [10]. To log
on, the participants had to use an autogenerated identification
code (eg, 1234abcd), a strong personal password, and a one-time
personal identification number sent to their mobile phone,
ensuring safety and anonymity. Inclusion and exclusion criteria
differed somewhat between the clinical trials, as did a few other
key characteristics (see Table 1) [11,12].
Individuals fulfilling the inclusion criteria and being deemed
eligible to participate were randomly assigned to ICBT with
guided self-help or to a waitlist control group. In total, 156 were
included in the Swedish trial (guided self-help n=78), compared
with 120 in the UK trial (guided self-help n=62). Those assigned
to the waitlist control later received the same treatment content,
either in a second wave of treatment (Swedish trial) or by being
given a self-help book (UK trial); we did not consider these
participants in this study. Further details regarding recruitment
and eligibility can be obtained elsewhere [8,9], as well as in
Table 1 and the flowchart in Figure 1. Table 2 shows the
baseline characteristics of the participants at pretreatment for
each clinical trial; the 2 trials differed on several baseline
characteristics. Overall, participants in the UK trial were more
likely to be single, be younger, report prior mental health
problems, have previous experience of undergoing psychological
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treatment and using psychotropic medication, and have greater
symptom severity on the FMPS CM, but not on the CPQ.
Measures
The main outcome measure in both trials was the FMPS CM
[5], comprising 9 items related to worries of making mistakes
that are scored on a 5-point Likert scale (range 1-5). The FMPS
CM has a Cronbach alpha of .88 [5]; in the 2 trials it was .85
(Swedish trial) and .74 (UK trial). Both trials also administered
the CPQ [6], comprising 12 items associated with a specific
construct of clinical perfectionism that are scored on a 4-point
Likert scale (range 0-3). The CPQ has a Cronbach alpha of .73
[6]; in the 2 trials it was .66 (Swedish trial) and .74 (UK trial).
The secondary outcome measures differed between the 2 clinical
trials but are nonetheless reported to examine the benefits on
conditions other than perfectionism. In the Swedish trial, these
were the 9-item Patient Health Questionnaire (PHQ-9) [13] and
the 7-item Generalized Anxiety Disorder scale (GAD-7) [14].
The PHQ-9 has 9 items related to depression that are scored on
a 4-point Likert scale (range 0-3), with a range in scores from
0 to 27. The PHQ-9 has a Cronbach alpha of .89 [13]; in
Swedish trial it was .84. The GAD-7 has 7 items measuring
worry and anxiety that are scored on a 4-point Likert scale
(range 0-3), with a range in scores from 0 to 21. The GAD-7
has a Cronbach alpha of .92 [14]; in the Swedish study it was
.87. The UK trial used the 21-item Depression Anxiety Stress
Scale (DASS-21) [15]. The DASS-21 has 21 items measuring
depression, anxiety, and stress that are scored on 4-point Likert
scale (range 0-3), with a range in scores from 0 to 63. The
DASS-21 has a Cronbach alpha of .88 [16]; in the UK study it
was .91.
Table 1. Key characteristics of the clinical trials. FMPS CM: Frost Multidimensional Perfectionism Scale, Concern over Mistakes subscale; SMS: short
message service text messaging.
UK trialSwedish trialCharacteristic
Self-referralsSelf-referralsRecruitment process
Yes (≥29 on the FMPS CM)NoCutoff criteria for maladaptive perfectionism
NoYes (Mini-International Neuropsychiatric Interview)Telephone interview assessment
Inclusion criteria
Yes (>18 years)Yes (>18 years)Minimum age
AllowedNot allowedConcurrent psychological treatment
AllowedNot allowedChange in pharmacological treatmenta
Allowed (except suicidality)Not allowed (eg, anorexia nervosa)Other more severe conditions
Yes (continuous)Yes (once)Randomization
NoYesConfirmation to commence treatment
Individual starting datesSimultaneous for all participantsStarting date
Yes (weekly but with no specification)Yes (on 2 predetermined weekdays)Guidance from a therapist
Mixed (undergraduate to PhD)Master’s degreeTherapist level
Yes (monthly)Yes (weekly)Therapist supervision
YesNoFeedback checked by supervisor
Egan et al [11]Egan et al [11]bTreatment protocol
12 weeks8 weeksTreatment period
6 months12 monthsFollow-up
EmailTelephone, email, and SMSFollow-up reminders
Yes (£10)cNoMonetary compensation
Yes (project identifier 6222:001)Yes (Dnr 2015/419-31)Ethics approval
Yes [12]NoStudy protocol
Yes (registration no. NCT02756871)NoRegistered at ClinicalTrials.gov
YesYesInformed consent obtained
aAny change 3 months prior to the screening process.
bMinor change in order of modules and greater emphasis on behavioral interventions.
cIf participant completed posttreatment assessment.
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Figure 1. Flow of participants through the study. ICBT: Internet-based cognitive behavioral therapy; MINI: Mini-International Neuropsychiatric
Interview.
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Table 2. Baseline characteristics of the participants at pretreatment assessments. FMPS CM: Frost Multidimensional Perfectionism Scale, Concern
over Mistakes subscale; N/A: not applicable.
95% CIdfχ2Swedish trial (n=78)UK trial (n=62)Baseline characteristic
N/A10.264 (82.1)49 (79.0)Female sex, n (%)
2.6 to -8.7N/AN/A34.22 (9.9)a28.6 (8.3)Age (years), mean (SD)
N/A232.3Marital status, n (%)
23 (29.5)48 (77.4)aSingle
52 (66.7)a14 (22.6)Married/partner
3 (3.8)0 (0.0)Divorced/widowed
N/A117.94 (5.1)20 (27.4)Prior mental health problem (yes), n (%)
N/A122.70 (0)16 (25.8)aPsychological treatment (yes), n (%)
N/A136.55 (6.4)11 (17.7)aPsychotropic medication (yes), n (%)
Primary outcome measures, mean (SD)
1.5 to 5.1N/AN/A33.4 (6.4)36.7 (4.4)aFMPS CM
–4.1 to –1.0N/AN/A38.3 (4.6)a35.7 (4.7)Clinical Perfectionism Questionnaire
aThe clinical trial with significantly higher values on a specific baseline characteristic.
Table 3. Modules and order of presentation in the clinical trials.
UK trialSwedish trialModule
Understanding your perfectionismUnderstanding your perfectionism1
Your own model, values, and motivationYour own model, values, and motivation2
Surveys and experimentsSurveys and experiments3
New ways of thinkingDealing with perfectionistic behaviors4
Dealing with perfectionistic behaviorsNew ways of thinking5
Self-criticism and self-compassionSelf-criticism and self-compassion6
Self-worthSelf-worth7
Maintain and continue positive changeMaintain and continue positive change8
The outcome measures were completed at pre- and posttreatment
and follow-up (12 months for the Swedish trial and 6 months
for the UK trial). The CPQ was also distributed weekly during
the treatment period for the UK trial.
Treatment and Therapists
In both clinical trials, the treatment content was derived from
Egan et al [11], administered as an ICBT with guided self-help.
It consisted of 8 modules, with 1 module delivered weekly,
including psychoeducation, exercises, and homework
assignments related to perfectionism. Each module was
approximately 12 pages, totaling 121 pages. However, there
were some minor differences between the 2 clinical trials in the
order the modules were distributed (see Table 3). In addition,
the Swedish trial put a greater emphasis on behavioral
interventions than did the UK trial. Also, the treatment period
was 8 weeks in the Swedish trial and 12 weeks in the UK trial.
Therapists in the Swedish trial were Master’s degree students
having completed 1.5 years of clinical training, compared with
a mixed set of therapists in the UK trial (undergraduates,
master’s degree students, doctoral candidates in clinical
psychology, and PhDs). In both cases, the therapists provided
the participants with weekly feedback, but while this was done
on predetermined weekdays in the Swedish trial, this was not
the case in the UK trial. The amount of therapist supervision
also differed between the 2 clinical trials: weekly for the
Swedish trial and monthly for the UK trial. Table 1 shows an
overview of the differences. A study protocol for the UK trial
is also available [12].
Statistical Analysis
Given the significant baseline differences between the 2 trials,
as well as the different lengths of follow-up, we did not combine
the data for any analyses. We calculated a priori power for the
2 clinical trials to detect significant differences compared with
the waitlist control at posttreatment, but not for a between-study
difference at follow-up. We explored differences between the
Swedish and the UK trial at baseline, as well as baseline
predictors of completion of the self-report measures at follow-up
(ie, dropouts, regardless of the number of modules they had
completed during the treatment period), by using 2-sided
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independent t tests for continuous variables and chi-square tests
for nominal variables.
We performed intention-to-treat analyses for the main and
secondary outcome measures using multiple imputation to
account for missing values and we conducted completer analyses
using available data. The imputation models used all available
self-report measures to create 10 imputed datasets. We then
used analysis of covariance (ANCOVA) to investigate the
change scores between pretreatment and follow-up, with scores
at baseline as covariates, averaging the parameter estimates for
the 10 analyses. All statistical analyses were done with IBM
SPSS version 24.0.0.1 (IBM Corporation).
Using the results from the ANCOVAs, we calculated
within-group effect sizes for the means of 2 assessments, divided
by the pooled standard deviations. All results are presented with
95% CIs, where applicable, including effect sizes, and discussed
in relation to similar findings in other clinical trials [17]. For
the FMPS CM, we defined recovery as having a score at
follow-up within 1 SD of that of the general population (<29
[18]; ie, a clinically significant change), with a change score
also exceeding the RCI (ie, 1.96 times the standard error of the
instrument [19]). This is assumed to reflect those participants
moving from a dysfunctional to a functional distribution in terms
of perfectionism. Furthermore, we determined improvement
using only the RCI as a cutoff. Also, nonresponse corresponded
to those participants not exceeding the RCI in any direction,
while we calculated reliable deterioration using the RCI but in
a negative direction [20].
All presented results concern the 6- and 12-month follow-ups.
For a review of the outcomes at posttreatment, see Rozental et
al [8] and Shafran et al [9].
Results
Attrition and Adherence
There was no statistical difference between the 2 clinical trials
in attrition, defined as the number of participants who were
randomly assigned but did not complete the assessment at
follow-up. In the Swedish trial, 49 (63%) completed the
follow-up self-report measures, compared with 35 (57%) in the
UK trial (χ21=0.6, P=.45). None of the baseline characteristics
were related to attrition in either of the 2 clinical trials. With
regard to adherence, defined as the number of completed
modules during the treatment period, the 2 clinical trials differed
significantly, with a mean difference of 3.14 modules (95% CI
2.31-3.97), demonstrating that the participants in the Swedish
trial completed more modules than those in the UK trial, on
average.
Treatment Results
Table 4 shows the descriptive statistics for the primary and
secondary outcome measures. The ANCOVAs for the
intention-to-treat analyses revealed significant differences
between pretreatment and follow-up for all of the primary and
secondary outcome measures in both clinical trials. Table 5
shows within-group Cohen d effect sizes and their respective
95% CIs.
The completer analyses revealed significant differences for both
clinical trials between pretreatment and follow-up, revealing a
mean difference of 8.98 points (Swedish trial; 95% CI
7.07-10.89) and 10.35 points (UK trial; 95% CI 7.25-13.44) for
the FMPS CM. Results were similar for the CPQ: 8.69 points
(Swedish trial; 95% CI 6.61-10.77) and 11.10 (UK trial; 95%
CI 9.14-13.07). For the secondary outcome measures, the mean
differences in the Swedish trial were 3.57 points for the PHQ-9
(95% CI 2.28-4.86) and 3.22 points for the GAD-7 (95% CI
2.33-4.12). In the UK trial, the mean difference for the DASS
was 8.78 points (95% CI 4.16-13.40).
Table 4. Observed and estimated scores for each primary outcome measure, by clinical trial, intention-to-treat analysis, and completer analysis. FMPS:
Frost Multidimensional Perfectionism Scale, Concern over Mistakes subscale.
Completer analysisIntention-to-treat analysisMeasure and condition
Follow-upPretreatmentFollow-upPretreatment
nMean (SD)nMean (SD)nMean (SD)nMean (SD)
Swedish triala
4923.61 (7.60)7833.42 (6.44)7825.14 (7.23)7833.42 (6.44)FMPS CM
4929.51 (6.70)7838.26 (4.63)7829.63 (8.00)7838.26 (4.63)Clinical Perfectionism Questionnaire
495.47 (4.77)789.59 (5.63)786.45 (4.73)789.59 (5.63)9-item Patient Health Questionnaire
493.84 (3.41)787.83 (4.85)784.95 (3.72)787.83 (4.85)7-item Generalized Anxiety Disorder scale
UK trialb
2925.52 (8.07)6236.71 (4.42)6228.83 (7.80)6236.71 (4.42)FMPS CM
2924.55 (5.25)6235.69 (4.73)6227.25 (6.44)6235.69 (4.73)Clinical Perfectionism Questionnaire
2715.93 (12.52)6226.31 (12.82)6219.89 (13.11)6226.31 (12.82)21-item Depression Anxiety Stress Scale
a12-month follow-up.
b6-month follow-up.
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Table 5. Within-group effect sizes, Cohen d (95% CI). FMPS: Frost Multidimensional Perfectionism Scale, Concern over Mistakes subscale.
Completer analysisIntention-to-treat analysisMeasure and condition
Cohen d (95% CI)Cohen d (95% CI)
Swedish trial
1.42 (1.01-1.81)1.21 (0.86-1.54)FMPS CM
1.59 (1.17-1.98)1.32 (0.97-1.66)Clinical Perfectionism Questionnaire
0.77 (0.40-1.14)0.60 (0.28-0.92)9-item Patient Health Questionnaire
0.92 (0.54-1.29)0.67 (0.34-0.99)7-item Generalized Anxiety Disorder scale
UK trial
1.92 (1.38-2.43)1.24 (0.85-1.62)FMPS CM
2.27 (1.70-2.80)1.49 (1.09-1.88)Clinical Perfectionism Questionnaire
0.82 (0.34-1.28)0.50 (0.13-0.85)21-item Depression Anxiety Stress Scale
Improvement and Deterioration
Recovery on the FMPS CM was defined as those participants
having a score at follow-up within 1 SD of the general
population (<29; ie, clinically significant change) and exceeding
the RCI. According to this definition, 29/49 (59%) participants
in the Swedish trial and 15/35 (43%) in the UK trial met the
criteria for recovery at follow-up. Improvement—that is, having
a change score beyond the RCI at follow-up—was achieved by
31/49 (63%) in the Swedish trial and 18/35 (51%) in the UK
trial. Meanwhile, 17/49 (35%) in the Swedish trial and 11/35
(31%) in the UK trial did not respond. In none of these cases
was there a significant difference between the 2 clinical trials:
χ22 range 3.09 to 3.99, P value range .14 to .21. Only 1/84 (1%)
participant deteriorated.
Discussion
Principal Findings
This study evaluated the long-term benefits of ICBT with guided
self-help for perfectionism, indicating that the results at
follow-up were similar to and possibly even somewhat improved
from posttreatment. This suggests that ICBT with guidance
from a therapist could help individuals manage and overcome
their perfectionism in the long term. Compared with the findings
of Lloyd et al [4], in this study the within-group effect sizes for
perfectionism are similar, although that systematic review and
meta-analysis included data only from pre- and posttreatment
and not from follow-up. This is also true for depression and
anxiety, with average Hedges g effect sizes being 0.64 (95%
CI 0.35-0.92) and 0.52 (95% CI 0.23-0.81), respectively. In
other words, the findings from our study are in line with previous
research, suggesting that some long-term benefits can be
achieved for anxiety, depression, and stress as well. Given that
we could not combine the outcomes from the 2 clinical trials
due to the differences in several key characteristics, most notably
not implementing the same follow-up period, the result s should
be interpreted with caution. Nevertheless, the results from this
study are comparable with those of Egan et al [7] at 6-month
follow-up, although, in that study, unguided self-help yielded
much lower effects than face-to-face CBT. Therefore, the use
of guided self-help when providing ICBT for perfectionism
might be assumed to be better than unguided self-help for
outcome. This idea was supported by a study on the differences
between various levels of guidance by a therapist in ICBT for
patients with depression [21] and, similarly, by a systematic
review and meta-analysis of self-guided interventions for
obsessive-compulsive disorder [22], indicating that more support
yields larger effects overall. However, Titov et al [23] did not
find such a difference in outcome, arguing that carefully
controlled ICBT without any support can be just as beneficial.
More research on the importance of guidance in relation to the
treatment of perfectionism with ICBT is thus warranted,
including an investigation of its influence on adherence.
The rates of recovery at follow-up, that is, those participants
meeting the criteria of moving from a dysfunctional to a
functional distribution in terms of perfectionism (clinically
significant change and exceeding the RCI) were 59% (FMPS
CM) in the Swedish trial and 43% (FMPS CM) in the UK trial.
This can be compared with the results of Egan et al [7] of 67%
for face-to-face CBT and 40% for unguided self-help. However,
given that, to our knowledge, no other clinical trial has
investigated recovery at follow-up, these numbers should be
interpreted cautiously and warrant replication. Furthermore,
given the high rate of attrition in this study, the estimates of
recovery might be unreliable because we derived them from
those participants completing the follow-up assessment, possibly
inflating the actual rates. In addition, it is unclear whether the
cutoff for determining clinically significant change (<29 on the
FMPS CM [18]) is sensitive enough to accurately differentiate
those belonging to a clinical population from those belonging
to a nonclinical population. In this sense, recovery in this study
should primarily be regarded as reaching a statistical criterion,
in line with the recommendations by Jacobson and Truax [24],
rather than true recovery in terms of no longer fulfilling the
criteria for a psychiatric disorder. Whether participants are in
fact recovered from perfectionism is, however, an issue that
requires both more empirical data and a better conceptual idea
of where the dysfunctional and functional distributions meet.
Nevertheless, the recovery rates indicate that ICBT works well
and does have an impact on perfectionism that should be
clinically relevant.
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Study Limitations
This study makes an important contribution to the research on
the treatment of perfectionism, as it is one of few studies that
included follow-up data and the only one to date, to our
knowledge, with follow-up at 12 months. There are, however,
also limitations that need to be addressed. First, issues related
to the design limit the conclusions that can be made. The 2
clinical trials differed on some key characteristics, including
different length of the treatment period (8 vs 12 weeks), therapist
experience, therapist supervision, and, especially, the timing of
the follow-up assessment. This was primarily due to different
conventions and logistical issues among the researchers
involved, meaning that the samples could not be combined and
thus limit power. Nevertheless, given the many similarities
between them in terms of treatment content and delivery, the
findings are arguably relevant to present together. Additionally,
there was no comparison group. However, replicating this study
is warranted, possibly by recruiting a larger and more
heterogeneous sample in the context of a randomized controlled
trial.
Second, attrition was high in both clinical trials, with only 63%
(Swedish trial) and 57% (UK trial) completing the self-report
measures at 6- and 12-month follow-up, respectively, potentially
affecting the conclusions that can be drawn. This can be
compared with a study on ICBT for procrastination [25], which
had 32% attrition at 12-month follow-up, suggesting that our
clinical trials both had higher rates of dropouts. In addition, an
individual patient data meta-analysis of 10 studies on ICBT for
depression indicated that 40% dropped out before completing
one-fourth of the modules [26]. Multiple imputation was used
to account for missing values, given the indication that data
were missing at random. In our study, none of the baseline
characteristics were associated with attrition, but this does not
preclude other variables that we did not explore from being
related to completing the self-report measures at follow-up.
Preventing attrition is thus important, and future research should
try to implement ways of improving these rates, perhaps by
adding more support or the use of tailored modules [27].
Additional issues related to the different attrition rates in the 2
clinical trials have also been addressed by Shafran et al [9], such
as not explicitly asking the participants to confirm their
participation and the absence of a telephone interview
assessment in the UK trial, aspects that may have to be addressed
to a greater extent in future studies.
Third, perfectionism is not a psychiatric disorder in itself [1].
This complicates the issue of assessing eligibility to participate
in a clinical trial, but also of determining whether it is a
condition that actually requires a stand-alone treatment like the
one provided. However, given the close connection with eating
disorders, depression, and anxiety disorders [3], it is reasonable
to assume that elevated perfectionism is a common denominator
for many psychiatric disorders. Hence, interventions targeting
its mechanisms should be beneficial for many individuals by
providing a more transdiagnostic approach. This is supported
by the finding that benefits can be observed on many different
outcomes in clinical trials of perfectionism, such as depression
[7-9]. Still, more research needs to be done to investigate
whether a transdiagnostic approach adds something to a
disorder-specific treatment, for instance comparing their efficacy
in a head-to-head comparison for a particular psychiatric
disorder.
Fourth, the participants in this study were all self-referred, and
although they scored high on perfectionism at pretreatment,
they may not be representative of individuals with this problem
in general. Arnberg et al [28] stressed that most individuals
receiving help via ICBT have a high educational level and are
more likely to be women and of a particular socioeconomic
group, possibly limiting the generalizability of the results.
However, Titov et al [29] compared the baseline characteristics
of individuals receiving ICBT with both those receiving CBT
at an outpatient clinic and those taking an epidemiological
survey, noting that the differences were small and not necessarily
important. In comparison with the general population, those
receiving treatment, regardless of format, had higher severity
levels overall, but ICBT and CBT did not differ from each other.
Also, with the only exceptions of age, sex, and marital status,
such aspects as educational level and employment status were
not different between ICBT and CBT treatment groups,
suggesting that there may not be anything specific to receiving
treatment via the internet with regard to those who seek help in
general. Further research should nonetheless be performed on
recruitment and diversity, preferably by limiting the number of
inclusion and exclusion criteria and by reaching out to a more
heterogeneous sample.
Conclusion
We examined the long-term benefits of ICBT with guided
self-help for perfectionism, depression, and anxiety. The results
at follow-up were comparable with posttreatment assessment,
obtaining medium to large within-group effect sizes. The results
from these 2 different cases of ICBT with guided self-help are
thus promising but warrant replication using a larger and more
heterogeneous sample.
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